Skip to main content
Premium Trial:

Request an Annual Quote

Timothy Kish, Christian Henry, Trevor Hawkins, Edward Barnholt, Paul Berg, Walter Gilbert, Frederick Sanger

Premium

Timothy Kish has resigned from his post as chief financial officer at Illumina, the company said during its first quarter conference call last week.

Kish, who will remain as a consultant to the San Diego life sciences company, will be replaced by Christian Henry, formerly CFO of Tickets.com. Henry previously served as vice president of finance and corporate controller at Affymetrix as well as chief accounting officer and corporate controller at Inhale Therapeutic Systems.


Trevor Hawkins has been appointed chief science and technology officer of MDS, the company announced last week.

Hawkins most recently served as president of molecular diagnostics at GE Healthcare as well as senior vice president of development at Amersham Biosciences. Hawkins holds a BS and PhD in biochemistry from the University of Sussex.


Edward Barnholt has been named to the board of directors of eBay, the online auctioneer said last week. Barnholt stepped down as chief executive officer of Agilent Technologies in March.


Nobel laureate Paul Berg, professor emeritus of cancer research at Stanford University and director emeritus for the Beckman Center for Molecular and Genetic Medicine, will receive the Biotechnology Heritage award to be presented by the Chemical Heritage Foundation and the Biotechnology Industry Organization at BIO 2005 in Philadelphia, the organizations said last week. Berg, along with Walter Gilbert and Frederick Sanger, received the 1980 Nobel Prize in chemistry for developing methods that make it possible to map the structure and function of DNA.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.